QSimulate leverages quantum mechanics to provide simulations that aid in drug discovery, materials design, and quantum computing applications.

QSimulate

QSimulate | 1,827 followers on LinkedIn. Leveraging the power of quantum mechanics to solve industrial-scale problems like never before. | As QSimulate is expanding the team, we have multiple open positions including scientists, software engineers, project management, and business development.

Our offices are located in Boston MA, Berkeley CA, and Ghent, Belgium. For technical positions, we also consider remote options.

Vice President of Product at QSimulate

David Pearlman

Health & Bio Investor

Enke Bashllari, Ph.D.

Senior Scientist at QSimulate

Daniel Moberg

Software Engineer at QSimulate

Fredy Aquino

Trevor Barsamian , director of business development, shares how QUELO scales simulations and optimizes computing costs for drug discovery. Learn more about QUELO: https://lnkd.in/eFi88qQh

Why quantum for drug lead optimization? Our QUELO customer says: "...the ability to incorporate quantum mechanics into dynamics-based relative free energy methods bodes well for increasing the predictive accuracy of RBFE calculations against challenging targets." Learn more about QUELO, our quantum-enhanced lead optimization solution: https://lnkd.in/eFi88qQh

QSimulate CEO, Toru Shiozaki , is joining the panel at "Wine with AI Category Leaders" on October 15th, hosted by Hyperlink Ventures , OCV , and Mucker Capital during LA Tech Week. If you are in the LA area, we would love to see you there! Event link: https://lnkd.in/efn966qx

QSimulate will be at SC24 in Atlanta on Nov. 19-20! Stop by our demo pod within the AWS booth between 2-4 pm to learn more about what the optimal balance of simulation accuracy and compute efficiency can do for your discovery efforts.

Did you miss the live webinar for QUELO's state-of-the-art quantum-powered AI force field? You're in luck! Watch the recording of David Pearlman as he shares the latest update to QUELO, our quantum-enhanced lead optimization solution. Register here for the webinar on-demand: https://lnkd.in/euiuzp9A

Don't forget to register for this week's webinar introducing quantum-powered AI force fields! On Thursday, September 26, David Pearlman will discuss the latest innovation in our quantum-enhanced lead optimization solution, QUELO. Register now: https://lnkd.in/e3Bw9tWi

Attention Drug Discovery Leaders! Are you looking to achieve the perfect balance of accuracy and efficiency in lead optimization? Join us on Thursday, September 26 for an exclusive webinar introducing quantum-powered AI force fields—the latest innovation in our quantum-enhanced lead optimization solution, QUELO. Register now: https://lnkd.in/e3Bw9tWi

Are you a drug discovery leader curious about how quantum can positively impact your pipelines? Then David Pearlman ’s talk on September 18th at “QM in Pharma” is for you! David’s presentation highlights how the QM/MM approach (QUELO) leads to better results than traditional molecular mechanics methods in applications such as FEP and covalent ligand characterization. By developing a faster approach that can replace classical mechanics in molecular dynamics-based methods, QUELO has an immediate positive impact on drug discovery, especially in techniques like relative free energy calculations that require nanoseconds of sampling. Register here: https://lnkd.in/e4rvRgCM

Join David Pearlman in London on September 18th for his talk at "QM in Pharma" as he highlights QSimulate 's cutting-edge quantum technology. Register here: https://lnkd.in/e4rvRgCM Learn more about QSimulate's QM solutions: https://lnkd.in/ebTSsCrq

QSimulate provides quantum simulations to improve research and development in fields such as drug discovery and materials design.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 5, 2024 12:35 AM	e00ff803
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 5, 2024 12:35 AM	fda17424
crunchbase trigger	general	Nov 27, 2024 12:50 PM	b5c4996d
crunchbase profile	general
li profile	general	Nov 5, 2024 12:35 AM	0cc81d37
translate crunchbase fundingrounds	general
peers	general	Nov 5, 2024 12:35 AM	d66d3948
news basic	general	Nov 5, 2024 12:35 AM	1552fc0b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

QSIM

COM:QSIMULATE

QSimulate